Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular heterogeneity of endometrial cancer in the real-world: Biomarker patterns by tumor stage, histology, and molecular subtype.

Gynecologic oncology - 1 May 2026

Paranjpe Rutugandha, Chen Cai, Sun Yezhou, Hong Jin-Liern, Prabhu Vimalanand S, Meng Robin, Dunshee Diana R, Duska Linda R

Abstract excerpt

OBJECTIVE: To describe the prevalence and distribution of molecular biomarkers in endometrial cancer across tumor stage, histology, and molecular subtype using real-world data. METHODS: This retrospective cohort study used de-identified clinical and tumor sequencing data from the Oncology Research Information Exchange Network between 2006 and 2020. Patients diagnosed with endometrial cancer and next-generation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to DNA-Binding Proteins

Share to Endometrial Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to Neoplasm Staging

Share to PTEN Phosphohydrolase

Source

Identifiers

PMID: 41930527
DOI: 10.1016/j.ygyno.2026.03.006

Genes

ERBB2
PTEN
ARID1A
POLE
TP53
PIK3CA
ESR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular heterogeneity of endometrial cancer in the real-world: Biomarker patterns by tumor stage, histology, and molecular subtype.PMID 41930527Read ↗

Analysis of Differences in the Classification of Endometrial Cancer Patients in PolandSemantic proximity Read ↗

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read ↗

Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.Semantic proximity Read ↗

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read ↗

Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer.Semantic proximity Read ↗

Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort StudySemantic proximity Read ↗

Tumor immune microenvironment in endometrial cancer of different molecular subtypes: evidence from a retrospective observational study.Semantic proximity Read ↗

Molecular Characterization and Clinical Implications of Endometrial Cancer.Semantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care Center.Semantic proximity Read ↗

The mutational landscape of endometrial cancer.Semantic proximity Read ↗

The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.